Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.2
-58.22%
20%
—
46.24%
60%
—
5 Years
Score3.2
Net Growth-58.22%
Net Trend20%
Net Income Consistency—
Rev Growth46.24%
Rev Trend60%
Revenue Consistency—
Cardiff Oncology Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 366K to $ 593K and net income went from -$ 19M to -$ 45M. Revenue increased in 3 of those 5 years; net income in 1.
Between 2015 and 2025, revenue grew from $ 313K to $ 593K and net income went from -$ 27M to -$ 45M. Revenue increased in 5 of those 10 years; net income in 4.
Cardiff Oncology Inc currently holds a 5-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.99 | — |
1 Year2025-08-12 | $ 2.43 | -59.24% |
5 Years2021-08-12 | $ 5.91 | -83.24% |
10 Years2016-08-12 | $ 403.92 | -99.75% |
20 Years2006-08-11 | $ 518.40 | -99.81% |
All Time2004-07-27 | $ 1.62K | -99.94% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2004-07-27 |
|---|---|---|---|---|---|---|
| Price | $ 0.99 | $ 2.43 | $ 5.91 | $ 403.92 | $ 518.40 | $ 1.62K |
| Return | — | -59.24% | -83.24% | -99.75% | -99.81% | -99.94% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 525K | -$ 44M | $ 46M |
| 2025 | $ 593K | -$ 45M | $ 58M |
| 2024 | $ 683K | -$ 45M | $ 91M |
| 2023 | $ 488K | -$ 41M | $ 74M |
| 2022 | $ 386K | -$ 38M | $ 105M |
| 2021 | $ 359K | -$ 28M | $ 140M |
| 2020 | $ 366K | -$ 19M | $ 130M |
| 2019 | $ 244.63K | -$ 16M | $ 10M |
| 2018 | $ 378K | -$ 16M | $ 11M |
| 2017 | $ 505K | -$ 24M | $ 8M |
| 2016 | $ 381K | -$ 39M | $ 37M |
| 2015 | $ 313K | -$ 27M | $ 67M |
| 2014 | $ 280K | -$ 14M | $ 27M |
| 2013 | $ 259.25K | -$ 11M | $ 25M |
| 2012 | $ 450K | -$ 11M | $ 10M |
| 2011 | $ 257.7K | -$ 2M | $ 700.37K |
| 2010 | $ 265.67K | -$ 5M | $ 58.7K |
| 2009 | $ 650K | -$ 2M | $ 550K |
| 2005 | -$ 7M | -$ 5M | |
| IPO2004 | -$ 5M | -$ 1M |
Explore beyond CRDF
You're looking at Cardiff Oncology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
